From the research index
The paper comes from the research index. It wasn’t submitted here.
Многоцентровое двойное слепое плацебо-контролируемое рандомизированное исследование препарата Рунихол® у пациентов с неалкогольной жировой болезнью печени на фоне метаболического синдрома
Nikitin, Grinevich, Gordienko and 12 others
Clinical trial record
Registered before results. Outcomes may change.
Многоцентровое двойное слепое плацебо-контролируемое рандомизированное исследование препарата Рунихол® у пациентов с неалкогольной жировой болезнью печени на фоне метаболического синдрома
Nikitin, Grinevich, Gordienko and 12 others · NCT02930161
- Sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Started
- 30 May 2016
- Trial ID
- NCT02930161
Abstract
The study is designed to assess the safety and efficacy of different doses and dosing regimens of Runihol, tablets, enteric coated, produced by "NTFF" POLYSAN" (Russia), in prevention of liver disease progression in patients with non-alcoholic fatty liver disease and metabolic syndrome.